Navigation Links
Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy Stent™ Compared to the TAXUS® Stent Shown in Two Clinical Trial Subgroup Analyses
Date:5/17/2012

PARIS, May 17, 2012 /PRNewswire/ -- OrbusNeich today announced that two subgroup analyses from the REMEDEE trial assessing vascular healing of the company's Combo Dual Therapy Stent versus the TAXUS paclitaxel-eluting stent demonstrate an early advantage with the Combo Stent.  Presented at EuroPCR 2012, the data were obtained with frequency-domain optical coherence tomography (FD-OCT) and virtual histology-intravascular ultrasound (VH-IVUS) at nine-month follow-up.

An independent OCT core laboratory performed a blinded quantitative analysis of the percent strut coverage and in stent neointimal characteristics along with a qualitative assessment of neointimal tissue appearance and make-up of 23 Combo Stents and 10 TAXUS stents at nine-month follow-up.

Specifically, the data show that neointimal volumes and thicknesses as measured with OCT were comparable at nine months post-implantation for both the Combo Stent and TAXUS stent as determined by a blinded OCT core lab analysis. However, the qualitative analysis inside the stent showed a more homogenous neointimal tissue appearance in the Combo Stent compared to the TAXUS stent. In detail, the Combo Stent placements had statistically significant more homogeneous tissue appearance compared to the TAXUS stent placements (79.2% versus 40%).  Heterogeneous and layered tissue appearance was observed in 60% of the TAXUS stent placements and in 20.8% of the Combo Stent placements. Additionally, there were fewer microvessels and macrophage-like appearances inside the Combo Stent compared to the TAXUS stent: 8.3% versus 30% microvessels; 4.2% versus 10% macrophage-like appearances.

"These intriguing data possibly demonstrate a more homogenous tissue appearance with the Combo Stent versus a more heterogeneous appearance with the TAXUS stent in a blinded analysis," said Akiko Maehara, M.D.,director of Intravascular Imaging Core Laboratory at the Cardiovascular Research Foundation and assistant pro
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Saving Lives of California Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment
3. Saving Lives of Florida Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment
4. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
5. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
6. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
7. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
10. Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies
11. Potential Early Warning System for Lung Cancer Identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014 Research and ... of the  "Global Operating Room Equipment Market ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,An operating room ... in a healthcare facility used to perform ... advanced equipment, which ensures patient care and ...
(Date:8/22/2014)... , Aug. 22, 2014 /CNW/ - On Aug. ... , the Canadian Medical Association (CMA) voted on ... any plant material, including medicinal cannabis. Bedrocan Cannabis Corp., ... supportive of the CMA motion. The CMA ... particular hazards associated with smoking any plant material, including ...
(Date:8/22/2014)... Research and Markets has announced ... Catheter Industry Report 2014" report to their offering. ... Industry Report 2014 is a professional and in-depth study ... industry with a focus on the Chinese situation. ... including definitions, classifications, applications and industry chain structure. The ...
Breaking Medicine Technology:Global Operating Room Equipment Market 2014-2018: Key Vendors are Getinge, STERIS, Stykron and TRUMPF Medical Systems 2Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2Global and Chinese Intravenous Catheter Industry Report 2014 2
... 2012  The United States Patent & Trademark Office (USPTO) ... BDSI ) that the USPTO has rejected all claims ... No. 7,357,891 (the ,891 Patent) which is currently being ... (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) ...
... Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) ... provide this corporate update detailing the Company,s business ... acquisition of its wholly owned subsidiary Healthcare Distribution ... sector.  The U.S. pharmaceutical distribution sector is approximately ...
Cached Medicine Technology:US Patent Office Rejection of All Claims in Final Asserted MonoSol Patent Further Supports BioDelivery Sciences' Position 2US Patent Office Rejection of All Claims in Final Asserted MonoSol Patent Further Supports BioDelivery Sciences' Position 3Sunpeaks Ventures Enters $45 Billion Specialty Drug Distribution Sector 2Sunpeaks Ventures Enters $45 Billion Specialty Drug Distribution Sector 3
(Date:8/23/2014)... The MPWMD Board of Directors voted on Monday, ... sole source of water for commercial and industrial properties. ... Brown of Archworks, LLC in Carmel, California. , This ... a water district in the State of California has approved ... AWGs at this time can now be used as a ...
(Date:8/23/2014)... (PRWEB) August 23, 2014 Pixel Film Studios, ... announced today the release of ProIntro Vol.3, a customizable ... fresh and professional tile just by dragging ProIntro Vol.3 in ... "ProIntro Vol.3 is a definite time saver and i think ... pack with 30 beautifully designed titles made with Final Cut ...
(Date:8/23/2014)... Dealing with a drug or alcohol substance abuse ... is a child. Adolescent addiction has been an important issue ... a new helpline is now providing a valuable resource for ... a real addiction recovery center. , The Troubled Teens Atlanta ... the community. By calling (404) 975-2762, parents and their teens ...
(Date:8/23/2014)... Wilmington, NC (PRWEB) August 23, 2014 ... across North Carolina. It’s no different in Wilmington, NC. ... Young adults are falling victim to drug and alcohol ... young people are looking to overcome substance abuse, but ... Finding an adolescent treatment facility can be a challenge ...
(Date:8/23/2014)... 23, 2014 Summer vacation is almost over ... back in session. While shopping for school supplies and a ... Batzner encourages parents and students to also spend some time ... are excellent hitchhikers and thrive in heavily populated places,” said ... classrooms and dorms the perfect settings for bed bugs to ...
Breaking Medicine News(10 mins):Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:A new plugin was announced today, ProIntro Vol.3 from Pixel Film Studios for Final Cut Pro X 2Health News:Atlanta’s New Troubled Teen Helpline Is Making a Difference in the Community 2Health News:Troubled Teens Wilmington Helpline Guides Adolescents to the Path of Recovery 2Health News:Expert Advice for a Bed Bug-Free School Year 2
... in the American Journal of Clinical Nutrition it was observed ... the build up of plaque in the arteries that can ... can protect against the formation of plaque in the arteries. ... diagnosed with heart disease or who had suffered a heart ...
... breakthrough discovery, American researchers have found some of the first ... womb. There have always been theories that unborn babies will ... read to or played music while still in the womb. ... been questionable in the past because there has been little ...
... on the vision loss with lazy eye, but not in the ... of vision loss in the normal eye in the future.// At ... called lazy eye. ,Many countries routinely screen for lazy ... possible in that eye. Some, but not all, countries place high ...
... who are given antibiotics after being hospitalized have a lower risk ... Researchers from Croydon Hospital, England //say that the reduced risk ... playing a role in heart disease. The effect was seen regardless ... Helicobacter pylori or Chlamydia pneumoniae. ...
... new survey observe that many people are still not very much ... cancers account for about 4% of all malignancies. //The warning signs ... to a cure. But, as a survey by dental experts at ... ,The survey was part of a three day oral ...
... study, it shows little difference in outcome between radical and ... of the breast and the nodes under the armpit// - ... breast cancer. Surgeons are more likely to opt for a ... lump and conserves the breast. ,Researchers at the ...
Cached Medicine News:
... Modular Incubator Chamber has been used worldwide ... conditions for gas mixture and temperature. This ... reliable for in vitro fertilization, HIV isolation, ... environmental contiftions, organ culture and the culturing ...
... range of miniTHERM incubators is available, ensuring ... solution for their specific requirements. miniTHERM incubators ... compact and extremely space saving. Their size ... It is possible to stack up to ...
IR Autoflow Dual Chamber Over-Under Water-Jacketed CO 2 Inc....
3.0% Tryptone, 2.0% Yeast Extract, 1.0% MOPS free acid, 2.0% Glucose....
Medicine Products: